AstraZeneca Pharmaceuticals LP et al v. Fresenius Kabi USA, LLC
| AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited and AstraZeneca AB |
| Fresenius Kabi USA, LLC |
| 1:2017cv01795 |
| December 14, 2017 |
| US District Court for the District of Delaware |
| Wilmington Office |
| New Castle |
| Vacant Judgeship (2017) |
| Mary Pat Thynge |
| Patent |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 30, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 17 NOTICE of Appearance by David A. Bilson on behalf of Fresenius Kabi USA, LLC (Bilson, David) |
Filing 16
SO ORDERED re #15 Consent Judgment filed by AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca PLC, AstraZeneca AB. Signed by Judge Mary Pat Thynge on 1/22/18. (cak)
|
| Filing 15 PROPOSED CONSENT JUDGMENT by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Silver, Daniel) |
| CASE CLOSED per DI 16 (cak) |
| Pro Hac Vice Attorney Imron T. Aly for Fresenius Kabi USA, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| ***NOTE: If the parties jointly consent to Chief Magistrate Judge Thynges jurisdiction to conduct all proceedings in this case, then the Pretrial Conference and Trial will be presided over by Judge Thynge consistent with 28 U.S.C. 636. Otherwise, in accordance with the District Court's procedures for "Assignment of Cases to Visiting Judges" (issued May 26, 2017 and available on the District Court's website), upon the filing of a case-dispositive motion (e.g., a motion to dismiss, a motion for judgment on the pleadings, a motion for summary judgment, or initiation of the claim construction process in a patent case), VAC cases will be reassigned to a visiting District Judge, and any further dates in the Scheduling Order, including the Pretrial Conference and Trial dates, may be adjusted dependent on the availability of the visiting District Judge. (cak) |
| Pro Hac Vice Attorney Caitlin Hogan for AstraZeneca Pharmaceuticals LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
|
SO ORDERED D.I. #10 MOTION for Pro Hac Vice Appearance of Attorney Filko Prugo and Caitlin Hogan filed by AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca PLC, AstraZeneca AB, #13 MOTION for Pro Hac Vice Appearance of Attorney Imron T. Aly and Christine Feller filed by Fresenius Kabi USA, LLC, #12 MOTION for Pro Hac Vice Appearance of Attorney Eberle Schultz filed by AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca PLC, AstraZeneca AB. Ordered by Judge Mary Pat Thynge on 12/28/2017. (dlb) Modified on 12/28/2017 (dlb).
|
|
SO ORDERED D.I. #14 STIPULATION TO EXTEND TIME Plaintiffs Shall Respond to Defendant's Counterclaims to February 5, 2018 filed by AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca PLC, AstraZeneca AB. Ordered by Judge Mary Pat Thynge on 12/27/2017. (dlb)
|
| Filing 14 STIPULATION TO EXTEND TIME Plaintiffs Shall Respond to Defendant's Counterclaims to February 5, 2018 - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Silver, Daniel) |
| Filing 13 MOTION for Pro Hac Vice Appearance of Attorney Imron T. Aly and Christine Feller - filed by Fresenius Kabi USA, LLC. (Attachments: #1 Certification of Imron T. Aly, #2 Certification of Christine Feller)Motions referred to Mary Pat Thynge.(Haney, Megan) |
| Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Eberle Schultz - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Attachments: #1 Certification for Eberle Schultz)(Silver, Daniel) |
| Case Assigned to Vacant Judgeship (2017). Please include initials of VAC after the case number on all documents filed. (rjb) |
| CASE REFERRED to Magistrate Judge Mary Pat Thynge. (This matter has been assigned to the Vacant Judgeship and referred to a Magistrate Judge for handling through case-dispositive motions. The Magistrate Judge has full authority permitted by law to manage this matter, including entering schedules through trial, deciding non-dispositive matters and making recommendations as to the resolution of dispositive matters. Litigants and counsel are reminded that they have the option of consenting to the Magistrate Judge to handle the case in full, including trial, or consenting to having a particular motion resolved by the Magistrate Judge.) Motions referred to Mary Pat Thynge.(rjb) |
| Filing 11 NOTICE of Appearance by Daniel M. Silver on behalf of AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited (Silver, Daniel) |
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Filko Prugo and Caitlin Hogan - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Attachments: #1 Certifications for Filko Prugo and Caitlin Hogan)(Silver, Daniel) |
| Filing 9 NOTICE of Appearance by Megan C. Haney on behalf of Fresenius Kabi USA, LLC (Haney, Megan) |
| Filing 8 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Fresenius SE & Co. KGaA for Fresenius Kabi USA, LLC filed by Fresenius Kabi USA, LLC. (Phillips, John) |
| Filing 7 ANSWER to #1 Complaint, Separate Defenses and, COUNTERCLAIM against AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited by Fresenius Kabi USA, LLC.(Phillips, John) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (fms) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca UK Limited filed by AstraZeneca UK Limited. (fms) |
| Filing 4 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP filed by AstraZeneca Pharmaceuticals LP. (fms) |
| Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,774,122; 7,456,160; 8,329,680; 8,466,139. (fms) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (fms) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Fresenius Kabi USA, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2284691.) - filed by AstraZeneca Pharmaceuticals LP, AstraZeneca AB, AstraZeneca UK Limited. (Attachments: #1 Appendix A-E, #2 Civil Cover Sheet)(fms) |
| Summons Issued with Magistrate Consent Notice attached as to Fresenius Kabi USA, LLC on 12/14/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (fms) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
